Newer Techniques for Prostate Surgery - UroLift , Rezum , I-TIND and Prostate Artery Embolization

Frequently asked questions

Q: What is the UroLift System and how does it work?

A: UroLift is a minimally invasive procedure for Benign Prostatic Hyperplasia (BPH). It uses small permanent implants (delivered via a delivery device passed through the urethra) to pull apart (lift) enlarged prostate tissue so it no longer compresses the urethra — without cutting, heating, or removing tissue

Q: Who is a good candidate for UroLift?

A: Typically, men with BPH symptoms (urinary frequency/urgency, weak flow, incomplete emptying, etc.), often 45 years or older, who want relief without major surgery, and desire to avoid lifelong BPH medications. Important to check for allergies to implant materials (e.g., nickel, titanium, stainless steel) before treatment

Q: What should I expect during and after the procedure? Is it painful? What about recovery and side-effects?

A: The procedure is minimally invasive, generally done under local or general anesthesia, and sometimes as an outpatient.

Common side effects: temporary discomfort or burning during urination, blood in urine, pelvic pain, urinary urgency or urge incontinence. Most of these resolve within 2–4 weeks. There is no cutting or tissue removal, so recovery tends to be quicker and less invasive than standard surgery.

Q: Will UroLift affect sexual function? And is the result permanent?

A: Clinical studies have shown that UroLift does not cause new, sustained erectile or ejaculatory dysfunction — a big advantage over some traditional BPH surgeries. The implants are intended as permanent. However, UroLift doesn’t rule out future BPH treatments if needed

Q: How can I contact you?

You can reach us by phone on +91-7703903478 and by email on ritesh.urology@gmail.com. We are always happy to answer your questions.

Q: What is the iTind procedure and how does it work?

A: iTind is a minimally invasive BPH treatment where a temporary nitinol device is placed via the urethra and left in place for 5–7 days. Over that time, it gently expands and reshapes (remodels) the prostatic urethra to widen the urine flow channel — without cutting, heating, or removing prostate tissue. After 5–7 days the device is removed; no permanent implant remains.

Q: Who is a suitable candidate for iTind?

A: Men with lower urinary tract symptoms (LUTS) due to BPH who want an alternative to daily medications or more invasive surgery. Often offered to men 50+ years who want to preserve sexual/ejaculatory function and avoid permanent implants or extensive surgery.

Q: What is Rezum Water Vapor Therapy and how does it treat BPH?

A: Rezum uses convective water-vapor thermal energy (steam) delivered via a needle into the prostate. The heat causes targeted prostate tissue destruction (cell death), which reduces the bulk of the prostate and relieves urethral compression.

Q: Who may benefit from Rezum therapy? (Who is a good candidate?)

A: Men with BPH (symptomatic) — often those ≥ 50 years and with a prostate volume within a certain range (e.g., 30 to ~80 cm³ per some data) — especially those wanting a minimally invasive option and aiming to avoid lifelong medications or more invasive surgery

Q: How long do the results last? Is Rezum a permanent solution?

A: Clinical studies report sustained symptom improvement for up to 5 years post-treatment in many men. As with other BPH treatments, results can vary and some men might need additional therapy or re-treatment, though retreatment rates appear relatively low in long-term follow-up

Q: Who is a suitable candidate for PAE? When is PAE considered?

A: PAE may be offered to men with symptomatic BPH who either cannot tolerate or prefer to avoid traditional invasive surgery (like TURP), or when medications are ineffective or not suitable. Patient’s overall health (kidney function, vascular access, absence of contraindications to contrast dye) and prostate anatomy are considered during evaluation.